Reata Pharmaceuticals, Inc. - (RETA) Social Stream
Featured Post From StockTwits About RETA
$RETA >> BUY THE DIP >>>ospreyeye, published August 10, 2021
"The FDA has not listed any safety issues as significant issues. Additionally, FDA does not believe a Risk Evaluation and Mitigation Strategies (“REMS”) program is needed. The FDA also informed Reata that an Advisory Committee meeting is tentatively scheduled for Dec 8."
It's all good 👍 >> they actually had a positive earnings surprise >>
This is a dip load opportunity >>
Got calls! $$$$$